Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Aptevo Therapeutics Inc. (APVO) had Earnings per Share (EPS) (Basic) of $-1747.60 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-24.13M |
|
-- |
|
-- |
|
$24.60M |
|
$-24.60M |
|
$0.47M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.60M |
|
$-24.25M |
|
0.01M |
|
0.01M |
|
|
Earnings per Share (EPS) (Basic) |
$-1747.60 |
$-1747.60 |
|
| Balance Sheet Financials | |
$10.66M |
|
$0.54M |
|
$4.93M |
|
$15.59M |
|
$6.21M |
|
-- |
|
$4.63M |
|
$10.84M |
|
$4.75M |
|
$4.75M |
|
$4.75M |
|
0.07M |
|
| Cash Flow Statement Financials | |
$-23.79M |
|
-- |
|
$15.60M |
|
$16.90M |
|
$8.71M |
|
$-8.19M |
|
$1.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-507.47% |
|
-507.47% |
|
-154.77% |
|
-507.47% |
|
$63.48 |
|
$-1722.70 |
|
$-1722.70 |
|